908 Devices Inc.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
MASS$9.99-13.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Nine Months Ended September 30, | ||||||
| · · 2026 · · 2025 | ||||||
| Cash flows from operating activities: | | | | | | |
| Net income (loss) | | $(28,428) | | $15,315 | ||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | | | ||
| Depreciation and amortization expense | | 4,002 | | 3,354 | ||
| Stock-based compensation expense | | 7,048 | | 7,080 | ||
| Provision for inventory obsolescence | | 330 | | 378 | ||
| Net amortization of premiums and accretion of discounts on marketable securities | | | 327 | | | (641) |
| Loss on disposal of property and equipment | | | 12 | | | 133 |
| Gain on sale of Desktop Portfolio, net of transaction costs | | | — | | | (56,128) |
| Change in provision for credit losses | | | 254 | | | — |
| Change in fair value of contingent consideration | | | 12,518 | | | 19,999 |
| Amortization of debt issuance costs | | | 40 | | | — |
| Deferred tax liabilities | | | (104) | | | — |
| Changes in operating assets and liabilities, net of business combinations: | | | | | ||
| Accounts receivable, net | | (5,449) | | 546 | ||
| Inventory | | (2,077) | | (5,462) | ||
| Prepaid expenses and other current assets | | 4,596 | | (2,237) | ||
| Other long-term assets | | (171) | | 189 | ||
| Accounts payable and accrued expenses | | 6,073 | | (5,423) | ||
| Deferred revenue | | 2,522 | | (2,142) | ||
| Right-of-use operating lease assets | | 575 | | 1,563 | ||
| Operating lease liabilities | | (503) | | (1,531) | ||
| Net cash provided by (used in) operating activities | | 1,565 | | (25,007) | ||
| Cash flows from investing activities: | | | | | ||
| Purchases of property and equipment | | (267) | | (961) | ||
| Purchases of marketable securities | | | (35,071) | | | (54,276) |
| Acquisition of businesses, net of cash acquired | | | (12,523) | | | (2,000) |
| Proceeds from sale of Desktop Portfolio | | | — | | | 69,909 |
| Proceeds from maturities of marketable securities | | | 41,500 | | | 31,265 |
| Net cash provided by (used in) investing activities | | (6,361) | | 43,937 | ||
| Cash flows from financing activities: | | | | | ||
| Payments for withholding taxes on vested awards | | | (2,422) | | | (698) |
| Proceeds from issuance of common stock | | | 1,852 | | | 415 |
| Payments of deferred financing costs | | | (121) | | | — |
| Net cash used in financing activities | | (691) | | (283) | ||
| Effect of foreign exchange rate changes on cash and cash equivalents | | | (103) | | | 27 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | | (5,590) | | 18,674 | ||
| Cash, cash equivalents and restricted cash at beginning of period | | 70,592 | | 44,203 | ||
| Cash, cash equivalents and restricted cash at end of period | | $65,002 | | $62,877 | ||
| Supplemental disclosure of noncash investing and financing information: | | | | | ||
| Transfers of inventory to property and equipment | | $1,089 | | $513 | ||
| Fair value of common stock issued for contingent consideration payment of RedWave | | $25,323 | | $— | ||
| Fair value of common stock issued for acquisition of NIRLAB | | $1,726 | | $— | ||
| Reconciliation of cash, cash equivalents and restricted cash: | | | | | | |
| Cash and cash equivalents | | $63,611 | | $62,802 | ||
| Restricted cash included in prepaid expenses and other current assets | | | 1,316 | | — | |
| Restricted cash included in other long-term assets | | | 75 | | | 75 |
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows | | $65,002 | | $62,877 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.